Actelion Pharmaceuticals Ltd

Corporate ownership and the company’s role in compute infrastructure.

TypeOtherHQCH

Johnson & Johnson is the last parent traced, 1 ownership level above this company

ownership level above this company

supply relationships · 0 with suppliers, 0 with customers

linked facilities

export-control designations found

sovereign commitments to funds investing in this company

Scrutica id: org-sec-actelion-pharmaceuticals-ltd-ch

Ownership chain

The main chain follows the strongest parent claim by confidence, source authority and date. Other named parents appear alongside it.

Actelion Pharmaceuticals Ltd (CH)
Starting organisation.
Johnson & Johnson (US)JNJ · CIK 200406
Per SEC EDGAR, as of 2026-02-11 (HIGHtier 1): The SEC record names Johnson & Johnson; Scrutica has not confirmed it as the immediate parent.

End of the displayed chain

The displayed ownership chain ends at Johnson & Johnson (JNJ · CIK 200406)

Related analysis

Headquarters country: Switzerland
Country profile with facility capacity, government AI programmes and export-control conditions.

Source coverage

Geographic revenue, business segments and capital allocation are unavailable from the corporate-financial extract. The record for Actelion Pharmaceuticals Ltd has no listing or filer identifier for matching to the corporate-financial extract. The public industry classification (SIC, NAICS) is also unrecorded. Sources and publication limits.

Loading company data…